CD19 and Hodgkins lymphoma: Notably, EVs specifically expressed cancer-related antigens (e.g., CD19 in B-cell neoplasms, CD38 in MM, CD13 in myeloid tumors, CD30 in HL), revealing that the total and antigen-specific count of EVs correlated with the clinical features.